I agree that we are definitely not that advanced, yet ;-)
- Forums
- ASX - By Stock
- NEU
- Ann: FDA approval for Phelan-McDermid IND and Phase 2 trial
NEU
neuren pharmaceuticals limited
Add to My Watchlist
9.89%
!
$13.78

Ann: FDA approval for Phelan-McDermid IND and Phase 2 trial, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.78 |
Change
1.240(9.89%) |
Mkt cap ! $1.730B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $9.542M | 697.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 404 | $13.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.78 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 389 | 13.750 |
3 | 199 | 13.740 |
4 | 411 | 13.730 |
2 | 348 | 13.720 |
8 | 1491 | 13.710 |
Price($) | Vol. | No. |
---|---|---|
13.770 | 983 | 2 |
13.780 | 388 | 3 |
13.790 | 428 | 4 |
13.800 | 1327 | 4 |
13.810 | 1536 | 6 |
Last trade - 12.41pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online